Personal Lifestyle Engine (PLX) - Personal Lifestyle Medicine Center (PLMC)

NCT04007939 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-10-30

No results posted yet for this study

Summary

It has been suggested that the best medicine should include four principles (4P) - Medicine should be personalized, predictive, preventative and participatory. Technology has provided the tools to collect data in ways not previously possible. Individuals can now collect information on their genome (including their genetic predisposition to tolerate medications and to respond to healthy lifestyle programs) that will modify their lifestyle and therapeutic choices. Beyond spot checks of vital signs and weight, individuals can now collect information on body composition, continuous monitoring of heart rate, blood pressure, and even blood sugar. Data on food consumption at a caloric, macronutrient and even micronutrient level can be collected. Standard medical histories and detailed physical examination findings and laboratory biomarkers can be correlated with this data.

Collections of individual patient data will need to be managed through computer programs and smart phone applications that provide direct feedback about the influence of lifestyle on health, wellness and biomarkers. To this end, Metagenics is designing and is launching a smart phone application, Personal Lifestyle Engine (PLX), for individual use by patients and their healthcare providers. The statistical analysis of these data is the primary objective of this study.

Conditions

  • Health, Subjective
  • Gastrointestinal Dysfunction
  • Cardiovascular Risk Factor
  • Autoimmune Diseases
  • Dental Diseases
  • Hormone Disturbance
  • Neurocognitive Dysfunction

Sponsors & Collaborators

  • MetaProteomics LLC

    collaborator INDUSTRY
  • Metagenics, Inc.

    lead INDUSTRY

Principal Investigators

  • Joseph Lamb, MD · Personalized Lifestyle Medicine Center

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2020-12-31
Completion
2022-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04007939 on ClinicalTrials.gov